Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database

BACKGROUND: Anti-HER2 therapy has evolved in the last years and an important role in this transformation was that of monoclonal antibodies and tyrosine kinase inhibitors. Considering their extended use in clinical practice, some toxicity problems have been highlighted around these drugs. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbieri, Maria Antonietta, Sorbara, Emanuela Elisa, Cicala, Giuseppe, Santoro, Vincenza, Cutroneo, Paola Maria, Franchina, Tindara, Spina, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844323/
https://www.ncbi.nlm.nih.gov/pubmed/34528216
http://dx.doi.org/10.1007/s40801-021-00278-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844323/
https://www.ncbi.nlm.nih.gov/pubmed/34528216
http://dx.doi.org/10.1007/s40801-021-00278-z

Ejemplares similares